GeneCard
|
Gene Name
|
Locus
|
Disorders
|
ABCB7 |
ATP-binding cassette, sub-family B (MDR/TAP), member 7 |
Xq13.1-q13.3 |
- Anemia, sideroblastic, with ataxia [MIM:301310]
|
ABCD1 |
ATP-binding cassette, sub-family D (ALD), member 1 |
Xq28 |
- Adrenoleukodystrophy [MIM:300100]
- Adrenomyeloneuropathy [MIM:300100]
|
ADFN |
albinism-deafness syndrome |
Xq26.3-q27.1 |
- Albinism-deafness syndrome
|
AGMX2 |
agammaglobulinemia, X-linked 2 (with growth hormone deficiency) |
Xp22 |
- Agammaglobulinemia, type 2, X-linked
|
AGTR2 |
angiotensin II receptor, type 2 |
Xq22-q23 |
- Mental retardation, X-linked-88
|
AIC |
Aicardi syndrome |
Xp22 |
- Aicardi syndrome
|
AIED |
Aland island eye disease (Forsius-Eriksson ocular albinism, ocular albinism type 2) |
Xp11.23 |
- Night blindness, congenital stationary, X-linked, type 2A [MIM:300071]
- Cone-rod dystrophy, X-linked, 3 [MIM:300476]
- Aland Island eye disease [MIM:300600]
|
AIH3 |
amelogenesis imperfecta 3, hypomaturation or hypoplastic type |
Xq22-q28 |
- Amelogenesis imperfecta-3, hypoplastic type
|
ALAS2 |
aminolevulinate, delta-, synthase 2 |
Xp11.21 |
- Anemia, sideroblastic/hypochromic
|
AMCX1 |
Arthrogryposis multiplex congenita, X-linked (spinal muscular atrophy, infantile, X-linked) |
Xp11.23 |
- Spinal muscular atrophy, X-linked 2, infantile [MIM:301830]
|
AMELX |
amelogenin (amelogenesis imperfecta 1, X-linked) |
Xp22.3-p22.1 |
- Amelogenesis imperfecta, hypoplastic/hypomaturation type [MIM:301200]
|
AMMECR1 |
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region, gene 1 |
Xq22.3 |
- Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis [MIM:300194]
|
ANOP1 |
anophthalmos 1 (with mental retardation, without limb anomalies or dental or urogenital abnormalities) |
Xq27-q28 |
- Microphthalmia, syndromic 4
|
AP1S2 |
adaptor-related protein complex 1, sigma 2 subunit |
Xp22 |
- Mental retardation, X-linked 59 [MIM:300630]
|
ARHGEF6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
Xq26 |
- Mental retardation, X-linked nonspecific, type 46 [MIM:300436]
|
ARHGEF9 |
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
Xq22.1 |
- Hyperekplexia and epilepsy [MIM:300607]
|
ARSE |
arylsulfatase E (chondrodysplasia punctata 1) |
Xp22.3 |
- Chondrodysplasia punctata, X-linked recessive [MIM:302950]
|
ARX |
aristaless related homeobox |
Xp22.13 |
- Infantile spasm syndrome [MIM:308350]
- Myoclonic epilepsy with mental retardation and spasticity [MIM:300432]
- Lissencephaly, X-linked with ambiguous genitalia [MIM:300215]
- Mental retardation, X-linked 36/43/54 [MIM:300419]
- Proud syndrome [MIM:300004]
- Partington syndrome [MIM:309510]
- Otahara syndrome [MIM:308350]
|
AR |
androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) |
Xq11-q12 |
- Androgen insensitivity [MIM:300068]
- Spinal and bulbar muscular atrophy of Kennedy [MIM:313200]
- Prostate cancer
- Breast cancer, male, with Reifenstein syndrome
- {Prostate cancer, susceptibility to} [MIM:176807]
- Hypospadias, perineal [MIM:300633]
|
ATP6AP2 |
ATPase, H+ transporting, lysosomal accessory protein 2 |
Xp11.4 |
- Mental retardation, X-linked, with epilepsy [MIM:300423]
|
ATP7A |
ATPase, Cu++ transporting, alpha polypeptide |
Xq12-q13 |
- Menkes disease [MIM:309400]
- Occipital horn syndrome [MIM:304150]
- Cutis laxa, neonatal
|
ATRX |
alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) |
Xq13 |
- Alpha-thalassemia/mental retardation syndrome [MIM:301040]
- Alpha-thalassemia myelodysplasia syndrome, somatic [MIM:300448]
- Mental retardation-hypotonic facies syndrome, X-linked [MIM:309580]
|
AUNX1 |
auditory neuropathy, X-linked recessive 1 |
Xq23-q27.3 |
- Deafness, X-linked 5
|
AVPR2 |
arginine vasopressin receptor 2 (nephrogenic diabetes insipidus) |
Xq28 |
- Diabetes insipidus, nephrogenic [MIM:304800]
- Nephrogenic syndrome of inappropriate antidiuresis [MIM:300539]
|
BCOR |
BCL6 co-repressor |
Xp11.4 |
- Microphthalmia, syndromic 2 [MIM:300166]
|
BFLS |
Borjeson-Forssman-Lehmann syndrome |
Xq26.3 |
- Mental retardation, X-linked, with isolated growth hormone deficiency [MIM:300123]
- Panhypopituitarism, X-linked [MIM:312000]
|
BMND4 |
Bone mineral density variation QTL 4 |
Xq27 |
- [Bone mineral density QTL 4]
|
BMP15 |
bone morphogenetic protein 15 |
Xp11.2 |
- Ovarian dysgenesis 2 [MIM:300510]
- Premature ovarian failure 4 [MIM:300510]
|
BPP |
Polymicrogyria, bilateral perisylvian |
Xq28 |
- Polymicrogyria, bilateral perisylvian
|
BRESEK |
BRESHECK syndrome |
X |
- BRESHECK syndrome
|
BRWD3 |
bromodomain and WD repeat domain containing 3 |
Xq13 |
- Mental retardation, X-linked 93 [MIM:300659]
|
BTK |
Bruton agammaglobulinemia tyrosine kinase |
Xq21.3-q22 |
- Agammaglobulinemia, type 1, X-linked
- XLA and isolated growth hormone deficiency [MIM:307200]
|
BZX |
Bazex syndrome |
Xq24-q27 |
- Bazex syndrome
|
C1GALT1C1 |
C1GALT1-specific chaperone 1 |
Xq23 |
- Tn syndrome [MIM:300622]
|
CACNA1F |
calcium channel, voltage-dependent, L type, alpha 1F subunit |
Xp11.23 |
- Night blindness, congenital stationary, X-linked, type 2A [MIM:300071]
- Cone-rod dystrophy, X-linked, 3 [MIM:300476]
- Aland Island eye disease [MIM:300600]
|
CCT |
cataract, congenital, total |
Xp |
- Cataract, congenital total
|
CD40LG |
CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) |
Xq26 |
- Immunodeficiency, X-linked, with hyper-IgM [MIM:308230]
|
CDKL5 |
cyclin-dependent kinase-like 5 |
Xp22 |
- Rett syndrome, atypical [MIM:312750]
- Infantile spasm syndrome, X-linked [MIM:308350]
|
CGF1 |
cognitive function 1, social |
Xq |
- [Social cognition]
|
CHDS3 |
Coronary heart disease, susceptibility to, 3 |
Xq23-q26 |
- {Coronary heart disease, susceptibility to, 3}
|
CHM |
choroideremia (Rab escort protein 1) |
Xq21.2 |
- Choroideremia [MIM:303100]
|
CLCN5 |
chloride channel 5 (nephrolithiasis 2, X-linked, Dent disease) |
Xp11.22 |
- Dent disease [MIM:300009]
- Nephrolithiasis, type I [MIM:310468]
- Hypophosphatemic rickets [MIM:300554]
- Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis [MIM:308990]
|
CMTX2 |
Charcot-Marie-Tooth neuropathy, X-linked 2 (recessive) |
Xp22.2 |
- Charcot-Marie-Tooth neuropathy, X-linked recessive, 2
|
CMTX3 |
Charcot-Marie-Tooth neuropathy, X-linked 3 (dominant) |
Xq26 |
- Charcot-Marie-Tooth neuropathy, X-linked recessive, 3
|
CND |
Corneal dermoids |
Xq24-qter |
- Dermoids of cornea
|
COD2 |
cone dystrophy 2 (X-linked) |
Xq27 |
- Cone dystrophy, progressive X-linked, 2
|
COL4A5 |
collagen, type IV, alpha 5 |
Xq22.3 |
- Alport syndrome [MIM:301050]
|
COL4A6 |
collagen, type IV, alpha 6 |
Xq22.3 |
- Leiomyomatosis, diffuse, with Alport syndrome [MIM:308940]
|
CPX |
cleft palate and/or ankyloglossia |
Xq12-q21 |
- Cleft palate with ankyloglossia [MIM:303400]
|
CSF2RA |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
Xp22.32 |
- Leukemia, acute myeloid, M2 type
|
CUL4B |
cullin 4B |
Xq23 |
- Mental retardation syndrome, X-linked, Cabezas type [MIM:300354]
- Mental retardation-hypotonic facies syndrome, X-linked, 2 [MIM:300639]
|
CVD1 |
cardiac valvular dysplasia-1 |
Xq28 |
- Cardiac valvular dysplasia-1
|
CVMRF |
cubitus valgus with mental retardation and unusual facies |
X |
- Cubitus valgus with mental retardation and unusual facies
|
CYBB |
cytochrome b-245, beta polypeptide |
Xp21.1 |
- Chronic granulomatous disease, X-linked [MIM:306400]
|
DCX |
doublecortex; lissencephaly, X-linked (doublecortin) |
Xq22.3-q23 |
- Lissencephaly, X-linked [MIM:300067]
- Subcortical laminal heteropia, X-linked [MIM:300067]
|
DDB1 |
damage-specific DNA binding protein 1, 127kDa |
11q12-q13 |
- Xeroderma pigmentosum, group E, subtype 2
|
DDB2 |
damage-specific DNA binding protein 2, 48kDa |
11p12-p11 |
- Xeroderma pigmentosum, group E, DDB-negative subtype [MIM:278740]
|
DFN2 |
deafness, X-linked 2, perceptive, congenital |
Xq22 |
- Deafness, X-linked 1
|
DFN4 |
deafness, X-linked 4, congenital sensorineural |
Xp21.2 |
- Deafness, X-linked 3
|
DFN6 |
deafness, X-linked 6, sensorineural |
Xp22 |
- Deafness, X-linked 4
|
DHOF |
dermal hypoplasia, focal |
Xp11.23 |
- Focal dermal hypoplasia [MIM:305600]
|
DIAPH2 |
diaphanous homolog 2 (Drosophila) |
Xq22 |
- Premature ovarian failure [MIM:300511]
|
DKC1 |
dyskeratosis congenita 1, dyskerin |
Xq28 |
- Dyskeratosis congenita-1 [MIM:305000]
- Hoyeraal-Hreidarsson syndrome [MIM:300240]
|
DLG3 |
discs, large homolog 3 (neuroendocrine-dlg, Drosophila) |
Xq13.1 |
- Mental retardation, X-linked-90
|
DMD |
dystrophin (muscular dystrophy, Duchenne and Becker types) |
Xp21.2 |
- Duchenne muscular dystrophy [MIM:310200]
- Becker muscular dystrophy [MIM:300376]
- Cardiomyopathy, dilated, 3B [MIM:302045]
|
DMRT1 |
doublesex and mab-3 related transcription factor 1 |
9p24.3 |
- XY sex reversal
|
DYT3 |
dystonia 3 (with Parkinsonism) |
Xq13 |
- Dystonia-Parkinsonism, X-linked [MIM:314250]
|
DYX9 |
dyslexia susceptibility 9 |
Xq27.3 |
- {Dyslexia, susceptibility to, 9}
|
EBP |
emopamil binding protein (sterol isomerase) |
Xp11.23-p11.22 |
- Chondrodysplasia punctata, X-linked dominant [MIM:302960]
|
EDA |
ectodysplasin A |
Xq12-q13.1 |
- Ectodermal dysplasia-1, anhidrotic [MIM:305100]
- Hypodontia, X-linked [MIM:300606]
|
EFMR |
epilepsy, female restricted, with mental retardation (Juberg-Hellman syndrome) |
Xq22 |
- Epilepsy, female restricted, with mental retardation
|
EFNB1 |
ephrin-B1 |
Xq12 |
- Craniofrontonasal dysplasia [MIM:304110]
|
ELK1 |
ELK1, member of ETS oncogene family |
Xp11.2 |
- mutations
|
EMD |
emerin |
Xq28 |
- Emery-Dreifuss muscular dystrophy [MIM:310300]
|
EMWX |
episodic muscle weakness, X-linked |
Xp22.3 |
- Episodic muscle weakness, X-linked
|
ERCC2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) |
19q13.2-q13.3 |
- Xeroderma pigmentosum, group D [MIM:278730]
- Trichothiodystrophy [MIM:601675]
- Cerebrooculofacioskeletal syndrome 2 [MIM:610756]
|
ERCC3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) |
2q21 |
- Xeroderma pigmentosum, group B [MIM:610651]
- Trichothiodystrophy [MIM:601675]
|
ERCC4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
16p13.3-p13.13 |
- Xeroderma pigmentosum, group F [MIM:278760]
- XFE progeroid syndrome [MIM:610965]
|
ERCC5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) |
13q33 |
- Xeroderma pigmentosum, group G [MIM:278780]
- Cerebrooculofacioskeletal syndrome 3
|
F8 |
coagulation factor VIII, procoagulant component |
Xq28 |
- Hemophilia A
|
F9 |
coagulation factor IX (plasma thromboplastic component, Christmas disease, hemophilia B) |
Xq27.1-q27.2 |
- Hemophilia B
- Warfarin sensitivity
|
FAM58A |
family with sequence similarity 58, member A |
Xq28 |
- STAR syndrome [MIM:300707]
|
FANCB |
Fanconi anemia, complementation group B |
Xp22.31 |
- Fanconi anemia, complementation group B [MIM:300514]
- VACTERL association with hydrocephalus, X-linked [MIM:314390]
|
FCP1 |
F-cell production 1 |
Xp22.2 |
- Fetal hemoglobin quantitative trait locus 3
|
FGD1 |
FYVE, RhoGEF and PH domain containing 1 (faciogenital dysplasia) |
Xp11.21 |
- Aarskog-Scott syndrome [MIM:305400]
- Mental retardation, X-linked nonsyndromic
|
FGS1 |
FG syndrome 1 |
Xq12-q21.31 |
- FG syndrome 1
|
FGS2 |
FG syndrome 2 |
Xq28 |
- FG syndrome 2
|
FGS3 |
FG syndrome 3 |
Xp22.3 |
- FG syndrome 3
|
FGS4 |
FG syndrome 4 |
Xp11.4-p11.3 |
- FG syndrome 4
|
FGS5 |
FG syndrome 5 |
Xq22.3 |
- FG syndrome 5
|
FLNA |
filamin A, alpha (actin binding protein 280) |
Xq28 |
- Heterotopia, periventricular [MIM:300049]
- Otopalatodigital syndrome, type I [MIM:311300]
- Otopalatodigital syndrome, type II [MIM:304120]
- Frontometaphyseal dysplasia [MIM:304120]
- Melnick-Needles syndrome [MIM:309350]
- Heterotopia, periventricular nodular, with frontometaphyseal dysplasia [MIM:300049]
- Heterotopia, periventricular, ED variant [MIM:300537]
|
FMR1 |
fragile X mental retardation 1 |
Xq27.3 |
- Fragile X syndrome [MIM:300624]
- Fragile X tremor/ataxia syndrome [MIM:300623]
|
FOXP3 |
forkhead box P3 |
Xp11.23-q13.3 |
- Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked [MIM:304790]
- {Diabetes mellitus, type I, susceptibility to} [MIM:222100]
|
FRAXA |
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation) |
Xq27.3 |
- Fragile X syndrome [MIM:300624]
- Fragile X tremor/ataxia syndrome [MIM:300623]
|
FRAXE |
fragile site, folic acid type, rare, fra(X)(q28) E |
Xq28 |
- Mental retardation, X-linked, FRAXE type
|
FRMD7 |
FERM domain containing 7 |
Xq26.2 |
- Nystagmus 1, congenital, X-linked [MIM:310700]
|
FTSJ1 |
FtsJ homolog 1 (E. coli) |
Xp11.23 |
- Mental retardation, X-linked-9 [MIM:309549]
|
FTX |
Thrombocytosis, familial X-linked |
X |
- Thrombocytosis, familial X-linked
|
G6PD |
glucose-6-phosphate dehydrogenase |
Xq28 |
- G6PD deficiency
- Favism
- Hemolytic anemia due to G6PD deficiency
|
GATA1 |
GATA binding protein 1 (globin transcription factor 1) |
Xp11.23 |
- Dyserythropoietic anemia with thrombocytopenia [MIM:300367]
- Macrothrombocytopenia [MIM:300367]
- Leukemia, megakaryoblastic, with or without Down syndrome [MIM:190685]
- Leukemia, megakaryoblastic, of Down syndrome [MIM:190685]
|
GDI1 |
GDP dissociation inhibitor 1 |
Xq28 |
- Mental retardation, X-linked nonspecific [MIM:309541]
|
GDXY |
gonadal dysgenesis, XY female type |
Xp22.11-p21.2 |
- Gonadal dysgenesis, XY female type
|
GJB1 |
gap junction protein, beta 1, 32kDa |
Xq13.1 |
- Charcot-Marie-Tooth neuropathy, X-linked dominant, 1 [MIM:302800]
|
GK |
glycerol kinase |
Xp21.3-p21.2 |
- Glycerol kinase deficiency [MIM:307030]
|
GLA |
galactosidase, alpha |
Xq22 |
- Fabry disease [MIM:301500]
- Fabry disease, cardiac variant [MIM:301500]
|
GPC3 |
glypican 3 |
Xq26 |
- Simpson-Golabi-Behmel syndrome, type 1 [MIM:312870]
- Wilms tumor, somatic [MIM:194070]
|
GPR143 |
G protein-coupled receptor 143 |
Xp22.3 |
- Ocular albinism, Nettleship-Falls type
|
GRDX |
Graves disease, susceptibility to, X-linked |
Xp11 |
- {Graves disease, susceptibility to, X-linked} [MIM:275000]
|
GRIA3 |
glutamate receptor, ionotrophic, AMPA 3 |
Xq25-q26 |
- Mental retardation, X-linked 94 [MIM:300699]
|
GRPR |
gastrin-releasing peptide receptor |
Xp22.3-p21.2 |
- mutations
|
GUST |
Gustavson mental retardation syndrome (with microcephaly, optic |
Xq26 |
- Gustavson syndrome
|
HCCS |
holocytochrome c synthase (cytochrome c heme-lyase) |
Xp22 |
- Microphthalmia, syndromic 7 [MIM:309801]
|
HDPA |
Hodgkin disease, susceptibility, pseudoautosomal |
Xpter-p22.32 |
- {Hodgkin disease susceptibility, pseudoautosomal}
|
HPRT1 |
hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) |
Xq26-q27.2 |
- Lesch-Nyhan syndrome, 300322
- HPRT-related gout [MIM:300323]
|
HPT |
hypoparathyroidism |
Xq26-q27 |
- Hypoparathyroidism, X-linked
|
HSD17B10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
Xp11.2 |
- 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency [MIM:300438]
- Mental retardation, X-linked syndromic 10 [MIM:300220]
- Mental retardation, X-linked 17/31, microduplication [MIM:300705]
|
HTC2 |
hypertrichosis 2 (generalized, congenital) |
Xq24-q27.1 |
- Hypertrichosis, congenital generalized
|
HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C |
Xq24 |
- mutations
|
HUWE1 |
HECT, UBA and WWE domain containing 1 |
Xp11.2 |
- Mental retardation, X-linked syndromic, Turner type [MIM:300706]
|
IDDMX |
Diabetes mellitus, insulin-dependent, X-linked, susceptibility to |
Xp11 |
- {Diabetes mellitus, insulin-dependent, X-linked}
|
IDS |
iduronate 2-sulfatase (Hunter syndrome) |
Xq28 |
- Mucopolysaccharidosis II
|
IGBP1 |
immunoglobulin (CD79A) binding protein 1 |
Xq13.1-q13.3 |
- Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia [MIM:300472]
|
IKBKG |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
Xq28 |
- Incontinentia pigmenti, type II [MIM:308300]
- Ectodermal dysplasia, hypohidrotic, with immune deficiency [MIM:300291]
- Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency [MIM:300301]
- Immunodeficiency, isolated [MIM:300584]
- {Atypical mycobacteriosis, familial} [MIM:300636]
- Invasive pneumococcal disease, recurrent isolated, 2 [MIM:300248]
|
IL1RAPL1 |
interleukin 1 receptor accessory protein-like 1 |
Xp22.1-p21.3 |
- Mental retardation, X-linked, 21/34 [MIM:300143]
|
IL2RG |
interleukin 2 receptor, gamma (severe combined immunodeficiency) |
Xq13 |
- Severe combined immunodeficiency, X-linked [MIM:300400]
- Combined immunodeficiency, X-linked, moderate [MIM:312863]
|
IMAGE |
Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies |
X |
- IMAGE syndrome
|
INDX |
Immunoneurologic syndrome X-linked, of Wood, Black, and Norbury |
Xq26-qter |
- Wood neuroimmunologic syndrome
|
IPOX |
Intestinal pseudoobstruction, neuronal, primary idiopathic |
Xq28 |
- Intestinal pseudoobstruction, neuronal, X-linked
|
IV |
inversus situs, viscerum |
Xq22.3 |
- Leiomyomatosis, diffuse, with Alport syndrome [MIM:308940]
|
JARID1C |
jumonji, AT rich interactive domain 1C |
Xp11.22-p11.21 |
- Mental retardation, X-linked, syndromic, JARID1C-related [MIM:300534]
|
KAL1 |
Kallmann syndrome 1 sequence |
Xp22.3 |
- Kallmann syndrome
|
KFSD |
keratosis follicularis spinulosa decalvans |
Xp22.1 |
- Keratosis follicularis spinulosa decalvans [MIM:308800]
|
KMS |
Kabuki mental retardation syndrome |
Xp22.3 |
- Kallmann syndrome
|
L1CAM |
L1 cell adhesion molecule |
Xq28 |
- Hydrocephalus due to aqueductal stenosis [MIM:307000]
- MASA syndrome [MIM:303350]
- CRASH syndrome [MIM:303350]
- Hydrocephalus with Hirschsprung disease and cleft palate [MIM:142623]
- Hydrocephalus with congenital idiopathic intestinal pseudoobstruction [MIM:307000]
- Corpus callosum, partial agenesis of [MIM:304100]
|
LAMP2 |
lysosomal-associated membrane protein 2 |
Xq24 |
- Glycogen storage disease IIb [MIM:300257]
|
MAA |
microphthalmia or anophthalmia and associated anomalies |
Xq27-q28 |
- Microphthalmia, syndromic 1
|
MAFD2 |
major affective disorder 2 |
Xq28 |
- {?Major affective disorder 2}
|
MAGT1 |
magnesium transporter 1 |
Xq13.1-q13.2 |
- Mental retardation, X-linked 95 [MIM:300716]
|
MAMLD1 |
mastermind-like domain containing 1 |
Xq28 |
- Hypospadias, X-linked [MIM:300633]
|
MAOA |
monoamine oxidase A |
Xp11.23 |
- Brunner syndrome
|
MAOB |
monoamine oxidase B |
Xp11.23 |
- monoamine oxidase deficiency
|
MCS |
Miles-Carpenter X-linked mental retardation syndrome |
Xq13-q22 |
- Mental retardation, X-linked, syndromic-4, with congenital contractures and low fingertip arches
|
MEAX |
myopathy with excessive autophagy |
Xq28 |
- Myopathy, X-linked, with excessive autophagy
|
MECP2 |
methyl CpG binding protein 2 (Rett syndrome) |
Xq28 |
- Rett syndrome [MIM:312750]
- Mental retardation, X-linked, syndromic 13 [MIM:300055]
- Rett syndrome, preserved speech variant [MIM:312750]
- Encephalopathy, neonatal severe [MIM:300673]
- {Autism, susceptibility to, X-linked-3} [MIM:300496]
- Angelman syndrome [MIM:105830]
- Mental retardation, X-linked, Lubs type, 300260 (3) X
|
MED12 |
mediator complex subunit 12 |
Xq13 |
- MED12-Related Disorders
|
MEHMO |
mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly and obesity syndrome |
Xp22.13-p21.1 |
- MEHMO syndrome
|
MENOQ1 |
menopause, natural, age at, QTL |
Xp21.3 |
- {Menopause, natural, age at, QTL}
|
MGC1 |
megalocornea 1 (X-linked) |
Xq21.3-q22 |
- Megalocornea, X-linked
|
MGR2 |
Migraine, familial typical, susceptibility to |
Xq |
- {Migraine, familial typical, susceptibility to, 1}
|
MID1 |
midline 1 (Opitz/BBB syndrome) |
Xp22 |
- Opitz G syndrome, type I [MIM:300000]
|
MNG2 |
multinodular goiter 2 |
Xp22 |
- Goiter, multinodular, 2
|
MPDMRS |
Martin-Probst deafness-mental retardation syndrome |
Xq11-q21 |
- Martin-Probst deafness-mental retardation syndrome
|
MRSA |
Mental retardation, X-linked, South African type |
Xq24-q27.3 |
- Mental retardation, X-linked, South African type
|
MRSD |
mental retardation-skeletal dysplasia |
Xq28 |
- Mental retardation-skeletal dysplasia
|
MRSS |
Mental retardation, X-linked, with short stature |
Xq24 |
- Mental retardation, X-linked, with short stature
|
MRX14 |
mental retardation, X-linked 14 |
Xp11.3-q13.3 |
- Mental retardation, X-linked 14
|
MRX17 |
mental retardation, X-linked 17 |
Xp11.2 |
- 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency [MIM:300438]
- Mental retardation, X-linked syndromic 10 [MIM:300220]
- Mental retardation, X-linked 17/31, microduplication [MIM:300705]
|
MRX1 |
mental retardation, X-linked 1 (non-dysmorphic) |
Xp11.3-q21.1 |
- Mental retardation, X-linked, 1
|
MRX20 |
mental retardation, X-linked 20 |
Xp11-q21 |
- Mental retardation, X-linked 20
|
MRX23 |
mental retardation, X-linked 23 |
Xq23-q24 |
- Mental retardation, X-linked 23, nonspecific
|
MRX27 |
mental retardation, X-linked 27 |
Xq23-q24 |
- Mental retardation, X-linked 23, nonspecific
|
MRX2 |
mental retardation, X-linked 2 (non-dysmorphic) |
Xp22.3 |
- Mental retardation, X-linked, 2
|
MRX31 |
mental retardation, X-linked 31 |
Xp11.2 |
- 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency [MIM:300438]
- Mental retardation, X-linked syndromic 10 [MIM:300220]
- Mental retardation, X-linked 17/31, microduplication [MIM:300705]
|
MRX35 |
mental retardation, X-linked 35 |
Xq23-q24 |
- Mental retardation, X-linked 23, nonspecific
|
MRX42 |
mental retardation, X-linked 42 |
Xq26 |
- Mental retardation, X-linked nonspecific, 42
|
MRX49 |
mental retardation, X-linked 49 |
Xp22.3 |
- Mental retardation, X-linked-49
|
MRX50 |
mental retardation, X-linked 50 |
Xp11.3-p11.21 |
- Mental retardation, X-linked nonspecific, type 50
|
MRX52 |
mental retardation, X-linked 52 |
Xp11.21-q22.3 |
- Mental retardation, X-linked 52
|
MRX53 |
mental retardation, X-linked 53 |
Xq22.2-q26 |
- Mental retardation, X-linked-53
|
MRX72 |
mental retardation, X-linked 72 |
Xq28 |
- Mental retardation, X-linked-72
|
MRX77 |
mental retardation, X-linked 77 |
Xq12-q21.3 |
- Mental retardation, X-linked 77
|
MRX78 |
mental retardation, X-linked 78 |
Xp11.4-p11.23 |
- Mental retardation, X-linked 78
|
MRX80 |
mental retardation, X-linked 80 |
Xq23-q24 |
- Mental retardation, X-linked 23, nonspecific
|
MRX81 |
mental retardation, X-linked 81 |
Xp11.2-q12 |
- Mental retardation, X-linked 81
|
MRX82 |
mental retardation, X-linked 82 |
Xq24-q25 |
- Mental retardation, X-linked 82
|
MRX84 |
mental retardation, X-linked 84 |
Xp11.3-q22.3 |
- Mental retardation, X-linked 84
|
MRXS10 |
mental retardation, X-linked, syndromic 10 |
Xp11.2 |
- 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency [MIM:300438]
- Mental retardation, X-linked syndromic 10 [MIM:300220]
- Mental retardation, X-linked 17/31, microduplication [MIM:300705]
|
MRXS11 |
mental retardation, X-linked, syndromic 11 |
Xq26-q27 |
- Mental retardation, X-linked, Shashi type
|
MRXS12 |
Mental retardation, X-linked, syndromic 12 |
Xp11 |
- Mental retardation, X-linked, syndromic 12
|
MRXS5 |
mental retardation, X-linked, syndromic 5 |
Xq25-q27 |
- Mental retardation, X-linked, syndromic-5, with Dandy-Walker malformation, basal ganglia disease, and seizures
|
MRXS7 |
mental retardation, X-linked, syndromic 7 |
Xp11.3-q22 |
- Mental retardation, X-linked, syndromic 7
|
MRXSAB |
Abidi X-linked mental retardation syndrome |
Xq13.2 |
- Mental retardation syndrome, X-linked, Abidi type
|
MRXSA |
Armfield X-linked mental retardation syndrome |
Xq28 |
- Mental retardation syndrome, X-linked, Armfield type
|
MRXSL |
Lubs X-linked mental retardation syndrome |
Xq28 |
- Mental retardation syndrome, X-linked, Lubs type
|
MTCP1 |
mature T-cell proliferation 1 |
Xq28 |
- prolymphocytic leukemia (T-PLL),with translocation t(X;14)(q28;q11) and breakpoint at MTCP1 locus
|
MTM1 |
myotubularin 1 |
Xq28 |
- Myotubular myopathy, X-linked [MIM:310400]
|
MYP1 |
myopia 1 (X-linked, Bornholm eye disease included) |
Xq28 |
- Myopia-1
- Bornholm eye disease
|
NAMSD |
neuropathy, axonal, motor-sensory with deafness and mental retardation (Cowchock syndrome) |
Xq24-q26.1 |
- Cowchock syndrome
|
NDP |
Norrie disease (pseudoglioma) |
Xp11.4 |
- Norrie disease
- Exudative vitreoretinopathy, X-linked [MIM:305390]
|
NDUFA1 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa |
Xq24 |
- Mitochondrial complex I deficiency [MIM:252010]
|
NHS |
Nance-Horan syndrome (congenital cataracts and dental anomalies) |
Xp22.13 |
- Nance-Horan syndrome [MIM:302350]
|
NLGN3 |
neuroligin 3 |
Xq13 |
- {Autism, susceptibility to, X-linked-1} [MIM:300425]
- {Asperger syndrome, susceptibility to, X-linked-1} [MIM:300494]
|
NPHL1 |
nephrolithiasis 1 (X-linked) |
Xp11.22 |
- Dent disease [MIM:300009]
- Nephrolithiasis, type I [MIM:310468]
- Hypophosphatemic rickets [MIM:300554]
- Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis [MIM:308990]
|
NR0B1 |
nuclear receptor subfamily 0, group B, member 1 |
? |
- X-Linked Adrenal Hypoplasia Congenita
|
NSDHL |
NAD(P) dependent steroid dehydrogenase-like |
Xq28 |
- CHILD syndrome [MIM:308050]
|
NYS5 |
Nystagmus 5, infantile periodic alternating |
X |
- Nystagmus 5, infantile periodic alternating
|
NYX |
nyctalopin |
Xp11.4 |
- Night blindness, congenital stationary, type 1 [MIM:310500]
|
OA1 |
Osteoarthritis QTL 1 |
Xp22.3 |
- Ocular albinism with sensorineural deafness
|
OA2 |
Osteoarthritis QTL 2 |
Xp11.23 |
- Night blindness, congenital stationary, X-linked, type 2A [MIM:300071]
- Cone-rod dystrophy, X-linked, 3 [MIM:300476]
- Aland Island eye disease [MIM:300600]
|
OASD |
ocular albinism and sensorineural deafness |
Xp22.3 |
- Ocular albinism with sensorineural deafness
|
OCRL |
oculocerebrorenal syndrome of Lowe |
Xq26.1 |
- Lowe syndrome [MIM:309000]
- Dent syndrome [MIM:300009]
|
ODPF |
Osseous dysplasia, digital, with facial pigmentary defects and multiple frenula |
Xq27.3-q28 |
- Osseous dysplasia, digital, with facial pigmentary defects and multiple frenula
|
OFD1 |
oral-facial-digital syndrome 1 |
Xp22.3-p22.2 |
- Oral-facial-digital syndrome 1 [MIM:311200]
- Simpson-Golabi-Behmel syndrome, type 2 [MIM:300209]
|
OPA2 |
optic atrophy 2 (obscure) |
Xp11.4-p11.21 |
- Optic atrophy, X-linked
|
OPHN1 |
oligophrenin 1 |
Xq12 |
- Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance [MIM:300486]
|
OPN1LW |
opsin 1 (cone pigments), long-wave-sensitive |
Xq28 |
- Colorblindness, protan
- Blue-cone monochromacy [MIM:303700]
|
OPN1MW |
opsin 1 (cone pigments), medium-wave-sensitive |
Xq28 |
- Colorblindness, deutan
- Blue-cone monochromacy [MIM:303700]
|
OSCS |
Osteopathia striata with cranial sclerosis |
X |
- Osteopathia striata with cranial sclerosis
|
OTC |
ornithine carbamoyltransferase |
Xp21.1 |
- Ornithine transcarbamylase deficiency [MIM:311250]
|
PAK3 |
p21 protein (Cdc42/Rac)-activated kinase 3 |
Xq21.3-q24 |
- Mental retardation, X-linked 30 [MIM:300558]
|
PARK12 |
Parkinson disease 12 |
Xq21-q25 |
- Parkinson disease 12 [MIM:168600]
|
PARP1 |
poly (ADP-ribose) polymerase 1 |
1q42 |
- Xeroderma pigmentosum
|
PDHA1 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
Xp22.2-p22.1 |
- Pyruvate dehydrogenase deficiency [MIM:312170]
- Leigh syndrome, X-linked [MIM:308930]
|
PDR |
pigment disorder, reticulate |
Xp22-p21 |
- Pigment disorder, reticulate
|
PGK1P1 |
phosphoglycerate kinase 1, pseudogene 1 |
Xq13 |
- Phosphoglycerate kinase 1 deficiency [MIM:300653]
|
PGK1P2 |
phosphoglycerate kinase 1, pseudogene 2 |
Xq13 |
- Phosphoglycerate kinase 1 deficiency [MIM:300653]
|
PGK1 |
phosphoglycerate kinase 1 |
Xq13 |
- Phosphoglycerate kinase 1 deficiency [MIM:300653]
|
PHEX |
phosphate regulating endopeptidase homolog, X-linked |
Xp22.2-p22.1 |
- Hypophosphatemia, X-linked [MIM:307800]
|
PHF6 |
PHD finger protein 6 |
Xq26.3 |
- Borjeson-Forssman-Lehmann syndrome [MIM:301900]
|
PHF8 |
PHD finger protein 8 |
Xp11.2 |
- Mental retardation syndrome, X-linked, Siderius type [MIM:300263]
|
PHKA1 |
phosphorylase kinase, alpha 1 (muscle) |
Xq13 |
- Muscle glycogenosis [MIM:300559]
|
PHKA2 |
phosphorylase kinase, alpha 2 (liver) |
Xp22.2-p22.1 |
- Glycogenosis, X-linked hepatic, type I
- Glycogenosis, X-linked hepatic, type II
|
PHP |
panhypopituitarism |
Xq27.2-q27.3 |
- Panhypopituitarism, X-linked
|
PIGA |
phosphatidylinositol glycan anchor biosynthesis, class A |
Xp22.1 |
- Paroxysmal nocturnal hemoglobinuria
|
PLP1 |
proteolipid protein 1 |
Xq22 |
- Pelizaeus-Merzbacher disease [MIM:312080]
- Spastic paraplegia-2 [MIM:312920]
|
POF1 |
premature ovarian failure 1 |
Xq26-q28 |
- Ovarian failure, premature
|
POLH |
polymerase (DNA directed), eta |
6p21.1-p12 |
- Xeroderma pigmentosum, variant type [MIM:278750]
|
PORCN |
porcupine homolog (Drosophila) |
Xp11.23 |
- Focal dermal hypoplasia [MIM:305600]
|
POU3F4 |
POU class 3 homeobox 4 |
Xq21.1 |
- Deafness, X-linked 2 [MIM:304400]
|
PQBP1 |
polyglutamine binding protein 1 |
Xp11.23 |
- Renpenning syndrome [MIM:309500]
- Golabi-Ito-Hall syndrome
|
PRPS1 |
phosphoribosyl pyrophosphate synthetase 1 |
Xq22-q24 |
- Gout, PRPS-related [MIM:300661]
- Phosphoribosylpyrophosphate synthetase superactivity [MIM:300661]
- Charcot-Marie-Tooth disease, X-linked recessive, 5 [MIM:311070]
- Arts syndrome [MIM:301835]
|
PRS |
Prieto X-linked mental retardation syndrome |
Xp11-q21 |
- Mental retardation, X-linked, syndromic-2, with dysmorphism and cerebral atrophy
|
PTOS2 |
Ptosis, hereditary congenital 2 |
Xq24-q27.1 |
- Ptosis, hereditary congenital 2
|
RFMN |
Roifman syndrome |
X |
- Roifman syndrome
|
RP23 |
retinitis pigmentosa 23 (X-linked recessive) |
Xp22 |
- Retinitis pigmentosa 23
|
RP24 |
retinitis pigmentosa 24 (X-linked recessive) |
Xq26-q27 |
- Retinitis pigmentosa-24
|
RP2 |
retinitis pigmentosa 2 (X-linked recessive) |
Xp11.3 |
- Retinitis pigmentosa-2
- Xp11.3 deletion syndrome [MIM:300578]
|
RP34 |
retinitis pigmentosa 34 (X-linked recessive) |
Xq28 |
- Retinitis pigmentosa 34
|
RP6 |
retinitis pigmentosa 6 (X-linked recessive) |
Xp21.3-p21.2 |
- Retinitis pigmentosa-6
|
RPGR |
retinitis pigmentosa GTPase regulator |
Xp21.1 |
- Retinitis pigmentosa-3 [MIM:300389]
- Cone-rod dystrophy [MIM:300029]
- Cone dystrophy-1 [MIM:304020]
- Retinitis pigmentosa, X-linked, with recurrent respiratory infections [MIM:300455]
- Macular degeneration, X-linked atrophic
- Retinitis pigmentosa, X-linked with deafness and sinorespiratory infections [MIM:300455]
|
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
Xp22.2-p22.1 |
- Coffin-Lowry syndrome [MIM:303600]
- Mental retardation, X-linked nonspecific, type 19
|
RRDX |
Radial ray deficiency |
Xq24-q25 |
- Radial ray deficiency
|
RS1 |
retinoschisin 1 |
Xp22.2-p22.1 |
- Retinoschisis
|
SAT1 |
spermidine/spermine N1-acetyltransferase 1 |
Xp22.1 |
- Keratosis follicularis spinulosa decalvans [MIM:308800]
|
SCAX1 |
spinocerebellar ataxia, X-linked 1 |
Xp11.21-q21.3 |
- Spinocerebellar ataxia, X-linked 1
|
SH2D1A |
SH2 domain protein 1A |
Xq25 |
- Lymphoproliferative syndrome, X-linked [MIM:308240]
|
SHFM2 |
split hand/foot malformation (ectrodactyly) type 2 |
Xq26 |
- Split hand/foot malformation, type 2
|
SHOX |
short stature homeobox |
Xpter-p22.32 |
- Short stature, idiopathic familial [MIM:300582]
- Leri-Weill dyschondrosteosis [MIM:127300]
- Langer mesomelic dysplasia [MIM:249700]
|
SHROOM4 |
shroom family member 4 |
Xp11.2 |
- Stocco dos Santos X-linked mental retardation syndrome [MIM:300434]
|
SLC16A2 |
solute carrier family 16, member 2 (monocarboxylic acid transporter 8) |
Xq13.2 |
- Allan-Herndon-Dudley syndrome [MIM:300523]
|
SLC6A14 |
solute carrier family 6 (amino acid transporter), member 14 |
Xq23-q24 |
- {Obesity, susceptibility to} [MIM:300306]
|
SLC6A8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
Xq28 |
- Creatine deficiency syndrome, X-linked [MIM:300352]
|
SLC9A6 |
solute carrier family 9 (sodium/hydrogen exchanger), member 6 |
Xq26.3 |
- Mental retardation, X-linked syndromic, Christianson type [MIM:300243]
|
SMAX3 |
spinal muscular atrophy, distal, X-linked recessive |
Xq13.1-q21 |
- Spinal muscular atrophy, distal, X-linked 3
|
SMS |
spermine synthase |
Xp22.1 |
- Mental retardation, X-linked, Snyder-Robinson type [MIM:309583]
|
SOX3 |
SRY (sex determining region Y)-box 3 |
Xq26.3 |
- Mental retardation, X-linked, with isolated growth hormone deficiency [MIM:300123]
- Panhypopituitarism, X-linked [MIM:312000]
|
SPG16 |
spastic paraplegia 16 (complicated, X-linked recessive) |
Xq11.2 |
- Spastic paraplegia-16, X-linked, complicated
|
SRPX2 |
sushi-repeat-containing protein, X-linked 2 |
Xq21.33-q23 |
- Roladic epilepsy, mental retardation, and speech dyspraxia [MIM:300642]
|
SRPX |
sushi-repeat-containing protein, X-linked |
Xp21.1 |
- mutations
|
SSX1 |
synovial sarcoma, X breakpoint 1 |
Xp11.2 |
- Sarcoma, synovial
|
SSX2 |
synovial sarcoma, X breakpoint 2 |
Xp11.2 |
- Sarcoma, synovial
|
SSX4 |
synovial sarcoma, X breakpoint 4 |
Xp11.2 |
- Sarcoma, synovial
|
STQTL6 |
stature quantitative trait locus 6 |
Xq24-q25 |
- Stature QTL 6
|
STS |
steroid sulfatase (microsomal), isozyme S |
Xp22.32 |
- Ichthyosis, X-linked
- Placental steroid sulfatase deficiency
|
SXI2 |
X inactivation, familial skewed, 2 |
Xq25-q26 |
- X inactivation, familial skewed, 2
|
SYN1 |
synapsin I |
Xp11.4-p11.2 |
- Epilepsy, X-linked, with variable learning disabilities and behavior disorders [MIM:300491]
|
TAF1 |
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa |
Xq13 |
- Dystonia-Parkinsonism, X-linked [MIM:314250]
|
TARPS |
Talipes equinovarus, atrial septal defect, Robin sequence, and persistence of left superior vena cava |
Xp11.23-q13.3 |
- TARP syndrome
|
TARP |
TCR gamma alternate reading frame protein |
Xp11.23-q13.3 |
- TARP syndrome
|
TBL1X |
transducin (beta)-like 1X-linked |
Xp22.3 |
- mutations
|
TBX22 |
T-box 22 |
Xq12-q21 |
- Cleft palate with ankyloglossia [MIM:303400]
|
TDFA |
Testis-determining factor, autosomal (ZFY-related autosomal) |
9p24 |
- XY sex reversal
|
TFE3 |
transcription factor binding to IGHM enhancer 3 |
Xp11.22 |
- Renal cell carcinoma, papillary, 1 [MIM:605074]
|
TGCT1 |
testicular germ cell tumor susceptibility 1 |
Xq27 |
- Testicular germ cell tumor
|
THAS |
thoracoabdominal syndrome |
Xq25-q26.1 |
- Thoracoabdominal syndrome
|
TIMM8A |
translocase of inner mitochondrial membrane 8 homolog A (yeast) |
Xq22 |
- Deafness, X-linked 1, progressive
- Mohr-Tranebjaerg syndrome [MIM:304700]
- Jensen syndrome [MIM:311150]
|
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
Xp11.3-p11.23 |
- mutations
|
TKCR |
torticollis, keloids, cryptorchidism and renal dysplasia |
Xq28 |
- Goeminne TKCR syndrome
|
TKTL1 |
transketolase-like 1 |
Xq28 |
- {?Wernicke-Korsakoff syndrome, susceptibility to}
|
TRAPPC2 |
trafficking protein particle complex 2 |
Xp22.2-p22.1 |
- Spondyloepiphyseal dysplasia tarda [MIM:313400]
|
TRO |
trophinin |
Xp11.22-p11.21 |
- mutations
|
UBE2A |
ubiquitin-conjugating enzyme E2A (RAD6 homolog) |
Xq24-q25 |
- Mental retardation, X-linked syndromic
|
UPF3B |
UPF3 regulator of nonsense transcripts homolog B (yeast) |
Xq25-q26 |
- Mental retardation, X-linked, syndromic 14 [MIM:300676]
|
VSPA |
Visuospatial/perceptual abilities |
Xp22.33 |
- Turner syndrome-associated neurocognitive phenotype
- [Visuospatial/perceptual abilities]
|
WAS |
Wiskott-Aldrich syndrome (eczema-thrombocytopenia) |
Xp11.23-p11.22 |
- Wiskott-Aldrich syndrome [MIM:301000]
- Thrombocytopenia, X-linked [MIM:313900]
- Neutropenia, severe congenital, X-linked [MIM:300299]
- Thrombocytopenia, X-linked, intermittent [MIM:313900]
|
WSN |
Waisman syndrome |
Xq28 |
- Waisman parkinsonism-mental retardation syndrome
|
WTS |
Wilson-Turner X-linked mental retardation syndrome |
Xp21.1-q22 |
- Mental retardation, X-linked, syndromic-6, with gynecomastia and obesity
|
WWS |
Wieacker-Wolff syndrome |
Xq13-q21 |
- Wieacker-Wolff syndrome
|
XBP1 |
X-box binding protein 1 |
22q12 |
- {Bipolar disorder, susceptibility to} [MIM:125480]
|
XCE |
X chromosome controlling element |
Xq13.2 |
- X-inactivation, familial skewed [MIM:300087]
|
XDH |
xanthine dehydrogenase |
2p23-p22 |
- Xanthinuria, type I [MIM:278300]
|
XGPY |
Xg pseudogene, Y-linked |
Xpter-p22.32 |
- [Blood group, XG system]
|
XG |
Xg blood group |
Xpter-p22.32 |
- [Blood group, XG system]
|
XIAP |
X-linked inhibitor of apoptosis |
Xq25 |
- Lymphoproliferative syndrome, X-linked, 2 [MIM:300635]
|
XIC |
X chromosome inactivation center |
Xq13.2 |
- X-inactivation, familial skewed [MIM:300087]
|
XIST |
X (inactive)-specific transcript (non-protein coding) |
Xq13.2 |
- X-inactivation, familial skewed [MIM:300087]
|
XK |
X-linked Kx blood group (McLeod syndrome) |
Xp21.2-p21.1 |
- McLeod syndrome
- McLeod syndrome with neuroacanthosis
|
XPA |
xeroderma pigmentosum, complementation group A |
9q22.3 |
- Xeroderma pigmentosum, group A [MIM:278700]
|
XPC |
xeroderma pigmentosum, complementation group C |
3p25 |
- Xeroderma pigmentosum, group C
|
XPNPEP2 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
Xq25 |
- {Angioedema induced by ACE inhibitors, susceptibility to}
|
XRCC1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
19q13.2 |
- mutations
|
XRCC2 |
X-ray repair complementing defective repair in Chinese hamster cells 2 |
7q36.1 |
- mutations
|
XRCC3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
14q32.3 |
- {Melanoma, cutaneous malignant, susceptibility to}
- {Breast cancer, susceptibility to}
|
ZDHHC15 |
zinc finger, DHHC-type containing 15 |
Xq13.3 |
- Mental retardation, X-linked-91 [MIM:300577]
|
ZIC3 |
Zic family member 3 (odd-paired homolog, Drosophila) |
Xq26.2 |
- Heterotaxy, X-linked visceral [MIM:306955]
|
ZNF41 |
zinc finger protein 41 |
Xp22.1-cen |
- Mental retardation, X-linked-89
|
ZNF674 |
zinc finger family member 674 |
Xp11 |
- Mental retardation, X-linked-92
|
ZNF81 |
zinc finger protein 81 |
Xp22.1-p11 |
- Mental retardation, X-linked 45 [MIM:300498]
|